[Lipids-Diagnosis and therapy in diabetes mellitus (Update 2019)].
Lipide: Diagnostik und Therapie bei Diabetes mellitus (Update 2019).
Diabetes mellitus
Hyperlipidemia
Statins
Journal
Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
pubmed:
14
4
2019
medline:
17
9
2019
entrez:
14
4
2019
Statut:
ppublish
Résumé
Hyper- and dyslipidemia contribute to cardiovascular morbidity and mortality in diabetic patients. Pharmacological therapy to lower LDL cholesterol has convincingly shown to reduce cardiovascular risk in diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the use of lipid-lowering drugs in diabetic patients according to current scientific evidence.
Identifiants
pubmed: 30980157
doi: 10.1007/s00508-019-1444-2
pii: 10.1007/s00508-019-1444-2
doi:
Substances chimiques
Hydroxymethylglutaryl-CoA Reductase Inhibitors
0
Hypolipidemic Agents
0
Lipids
0
Types de publication
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
136-138Références
N Engl J Med. 1999 Aug 5;341(6):410-8
pubmed: 10438259
Lancet. 2005 Oct 8;366(9493):1267-78
pubmed: 16214597
Lancet. 2005 Nov 26;366(9500):1849-61
pubmed: 16310551
Lancet. 2008 Jan 12;371(9607):117-25
pubmed: 18191683
N Engl J Med. 2010 Apr 29;362(17):1563-74
pubmed: 20228404
Lancet. 2012 Aug 11;380(9841):581-90
pubmed: 22607822
N Engl J Med. 2015 Jun 18;372(25):2387-97
pubmed: 26039521
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
N Engl J Med. 2017 May 4;376(18):1713-1722
pubmed: 28304224
Endocr Pract. 2018 Jan;24(1):91-120
pubmed: 29368965
N Engl J Med. 2018 Nov 29;379(22):2097-2107
pubmed: 30403574